Taken together, these data indicate that adipose‐specific CD146 KO prevents HFD‐induced obesity and lipid metabolism disorders, as well as significantly reducing obesity‐related insulin resistance and chronic inflammation. This evidence concerns the gene MCAM and Disorder of lipid metabolism.